NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRXP NRX Pharmaceuticals Inc.

交易中 10-20 10:28:24 EDT

2.70

+0.07

+2.66%

最高2.71	最低2.60	成交量24.62万
今开2.63	昨收2.63	日振幅4.18%
总市值1.17亿	流通市值1.01亿	总股本4,330万
成交额65.62万	换手率0.66%	流通股本3,742万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRXP","market":"US","secType":"STK","nameCN":"NRX Pharmaceuticals Inc.","latestPrice":2.7,"timestamp":1792506484603,"preClose":2.63,"halted":0,"volume":246248,"delay":0,"changeRate":0.02661596958174916,"floatShares":37421400,"shares":43295800,"eps":-0.775423,"marketStatus":"交易中","change":0.07,"latestTime":"10-20 10:28:24 EDT","open":2.63,"high":2.71,"low":2.6,"amount":656226.048952,"amplitude":0.041825,"askPrice":2.73,"askSize":1010,"bidPrice":2.71,"bidSize":927,"shortable":3,"etf":0,"ttmEps":-0.775423,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1792526400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":2.63,"preHourTrading":{"tag":"盘前","latestPrice":2.66,"preClose":2.63,"latestTime":"09:28 EDT","volume":5608,"amount":14753.100192,"timestamp":1792502880084,"change":0.03,"changeRate":0.011407,"amplitude":0.087452},"postHourTrading":{"tag":"盘后","latestPrice":2.68,"preClose":2.63,"latestTime":"19:58 EDT","volume":5564,"amount":14956.1909,"timestamp":1792454327593,"change":0.05,"changeRate":0.019011,"amplitude":0.019011},"volumeRatio":1.714053,"impliedVol":1.4728,"impliedVolPercentile":0.49},"requestUrl":"/m/hq/s/NRXP/wiki","defaultTab":"wiki","newsList":[{"id":"1124751817","title":"NRX Pharmaceuticals（纳斯达克：NRXP）发布2026年第二季度财务业绩并更新公司动态；电话会议定于8月17日（周一）美东时间下午4：30召开","url":"https://stock-news.laohu8.com/highlight/detail?id=1124751817","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124751817?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:01","pubTimestamp":1786964479,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals（纳斯达克股票代码：NRXP）今日正式披露了截至2026年6月30日的第二季度财务报告，并同步向市场通报了公司近期运营进展。\n根据公告，该公司已敲定将于2026年8月17日（星期一）美东时间下午4：30举行投资者电话会议，届时管理层将对季度业绩进行深度解读，并就未来发展路径与市场参与者展开交流。\n此番财报发布正值公司推进关键管线项目之际，市场对其现金消耗节奏、研发里程碑达成情况以及潜在的战略合作动向均投以密切关注。NRX Pharmaceuticals在神经科学及精神健康治疗领域的布局，将持续吸引投资者审视其价值主张。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177674010","title":"NRX Pharmaceuticals迎来转机：FDA将在2026年8月6日会议后以最快周期审核认证","url":"https://stock-news.laohu8.com/highlight/detail?id=1177674010","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177674010?lang=zh_cn&edition=full","pubTime":"2026-08-07 19:01","pubTimestamp":1786100476,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals（NRXP）迎来关键进展。美国食品药品监督管理局（FDA）已确认，将于2026年8月6日会议之后，采用最短可能的审批周期，对该公司提交的认证申请进行审查。这一安排意味着监管机构正以最高效率推进评估流程，有望大幅缩短该公司等待最终决定的漫长周期。对投资者而言，这一消息无疑为市场注入了新的变量与期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PSIL","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154218602","title":"NRX Pharmaceuticals：公司认为收购或放弃任何单一诊所对Hope整体商业模式均不构成重大影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1154218602","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154218602?lang=zh_cn&edition=full","pubTime":"2026-06-26 04:03","pubTimestamp":1782417795,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals Inc. 表示，无论收购还是放弃任何一家独立诊所，公司均不认为这会对“Hope”项目的整体商业模式产生实质性影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106163346","title":"NRX Pharmaceuticals子公司Hope Therapeutics采用Zeta Surgical经FDA批准的Zeta TMS导航系统完成首批患者治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1106163346","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106163346?lang=zh_cn&edition=full","pubTime":"2026-06-25 19:02","pubTimestamp":1782385357,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals旗下子公司Hope Therapeutics已成功运用Zeta Surgical公司获得美国食品药品监督管理局（FDA）批准的Zeta TMS导航系统，为首批患者提供了治疗。这一进展标志着该创新技术在临床实践中的初步应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159214495","title":"Kadima神经精神病学研究所：诉讼寻求法院判令强制被告按已签署协议条款完成交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1159214495","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159214495?lang=zh_cn&edition=full","pubTime":"2026-06-25 01:21","pubTimestamp":1782321694,"startTime":"0","endTime":"0","summary":"Kadima神经精神病学研究所已向法院提起诉讼，要求强制被告方履行已签署协议中的条款并完成交易。该诉讼旨在通过法律途径寻求特定履行，即要求法院下达命令，迫使被告方按照双方先前达成的协议内容，执行并完成相关交易。此举凸显了协议执行过程中出现的争议，并试图通过司法干预确保合约义务得到落实。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198462253","title":"Zeta Surgical® 宣布在Hope Therapeutics成功使用Zeta Tms导航系统完成首例患者治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1198462253","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198462253?lang=zh_cn&edition=full","pubTime":"2026-06-23 23:06","pubTimestamp":1782227178,"startTime":"0","endTime":"0","summary":"Zeta Surgical® 宣布，其Zeta Tms导航系统在Hope Therapeutics成功完成了首例患者的临床治疗。这一里程碑标志着该导航系统在临床应用上迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161710155","title":"NRX Pharmaceuticals宣布FDA批准扩大使用协议，将D-环丝氨酸为基础的NRX-101用于增强经颅磁刺激治疗抑郁症","url":"https://stock-news.laohu8.com/highlight/detail?id=1161710155","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161710155?lang=zh_cn&edition=full","pubTime":"2026-06-22 19:03","pubTimestamp":1782126201,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals宣布，美国食品药品监督管理局（FDA）已批准一项扩大使用协议，允许将基于D-环丝氨酸的NRX-101药物，作为经颅磁刺激治疗抑郁症方案的增强剂。\n这项协议意味着，符合条件的患者将能够提前获得这种尚在临床研究阶段的治疗组合。NRX-101是一种口服药物，旨在增强经颅磁刺激的神经可塑性效应，从而可能为对现有疗法反应不佳的抑郁症患者提供新的希望。\n扩大使用协议通常适用于患有严重或危及生命疾病的患者，且当没有可比或令人满意的替代疗法时。此举为部分患者提供了在药物正式获批上市前接受潜在有效治疗的途径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142463221","title":"NRX Pharmaceuticals Inc.完成2230万美元普通股公开发行，包销商期权获全额行使","url":"https://stock-news.laohu8.com/highlight/detail?id=1142463221","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142463221?lang=zh_cn&edition=full","pubTime":"2026-06-05 05:13","pubTimestamp":1780607593,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals Inc. 宣布，其普通股公开发行已成功完成，募集资金总额达2230万美元。此次发行包含了包销商期权的全额行使。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120213361","title":"NRX制药公司公布2026年第一季度财务业绩及企业动态更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1120213361","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120213361?lang=zh_cn&edition=full","pubTime":"2026-05-18 19:00","pubTimestamp":1779102044,"startTime":"0","endTime":"0","summary":"NRX制药公司（纳斯达克股票代码：NRXP）近日发布了其2026年第一季度的财务报告，并同步更新了公司近期的运营进展。\n公司管理层在报告中详细阐述了本季度的财务状况，包括收入、支出及研发投入等关键财务指标。与此同时，公告也涵盖了公司在核心药物研发管线、临床试验进度以及未来战略规划方面的最新信息。这些更新旨在向投资者全面展示公司在报告期内的经营成果与未来发展蓝图。\n财务业绩的披露为企业评估自身运营效率与资金状况提供了依据，而公司动态的分享则有助于市场了解其在产品开发与商业化道路上的具体步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193230332","title":"NRX Pharmaceuticals Inc. 将公布2026年第一季度财务业绩并更新公司动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1193230332","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193230332?lang=zh_cn&edition=full","pubTime":"2026-05-14 19:01","pubTimestamp":1778756490,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals Inc. (纳斯达克股票代码:NRXP) 宣布，即将发布其2026年第一季度的财务报告，并将同时提供公司业务进展的最新情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512485964","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大跌5.15%报2.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512485964?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:03","pubTimestamp":1739977417,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时03分，Nrx Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.15%。截至发稿，该股报2.58美元/股，成交量11.7498万股，换手率0.69%，振幅8.72%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230338a24c02d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230338a24c02d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512964391","title":"Nrx Pharmaceuticals, Inc.盘中异动 下午盘大幅下跌5.26%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512964391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512964391?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:18","pubTimestamp":1739906325,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时18分，Nrx Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.26%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031845abd3e9dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031845abd3e9dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510082333","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.94%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510082333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510082333?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:05","pubTimestamp":1739286321,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时05分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.94%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112305219881c3bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112305219881c3bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4139","OCEA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509744248","title":"Nrx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509744248?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:44","pubTimestamp":1738939494,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时44分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.03%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224454a23d266e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224454a23d266e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509358172","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509358172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509358172?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:53","pubTimestamp":1738770825,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时53分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.58%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.31%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205235345961917ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205235345961917ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508214081","title":"Nrx Pharmaceuticals, Inc.盘中异动 大幅拉升5.30%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508214081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508214081?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:48","pubTimestamp":1738597719,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时48分，Nrx Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.30%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为555.30%、425.10%、352.43%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为158.16%、75.23%、53.59%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032348399617085a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032348399617085a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508975189","title":"Nrx Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.02%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508975189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508975189?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:50","pubTimestamp":1738356612,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时50分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.02%。截至发稿，该股报3.14美元/股，成交量34.3327万股，换手率2.03%，振幅8.03%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201045012abbe7bf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201045012abbe7bf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507216076","title":"Nrx Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.05%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507216076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507216076?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:36","pubTimestamp":1738247762,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时36分，Nrx Pharmaceuticals, Inc.股票出现波动，股价急速下跌6.05%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223602a234561f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223602a234561f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507631922","title":"Nrx Pharmaceuticals, Inc.盘中异动 快速下跌5.97%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507631922?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:38","pubTimestamp":1738161494,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时38分，Nrx Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.97%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012922381498760ad9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012922381498760ad9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","NRXP","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506146825","title":"Nrx Pharmaceuticals, Inc.股价上涨10.14% 市值涨36.57万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506146825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506146825?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074696,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Nrx Pharmaceuticals, Inc.股票出现异动，股价大幅上涨10.14%。Nrx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Nrx Pharmaceuticals, Inc.公司简介：NRX Pharmaceuticals Inc 是一家临床阶段的小分子制药公司，开发并计划销售用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822313698756b6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822313698756b6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.salbergco.com","stockEarnings":[{"period":"1week","weight":-0.0772},{"period":"1month","weight":-0.2078},{"period":"3month","weight":-0.4103},{"period":"6month","weight":-0.1145},{"period":"1year","weight":-0.173},{"period":"ytd","weight":-0.0295}],"compareEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0243},{"period":"6month","weight":0.0777},{"period":"1year","weight":0.1537},{"period":"ytd","weight":0.124}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NRx Pharmaceuticals, Inc.是于2015年5月20日依照特拉华州法律成立的公司。该公司是一家临床阶段的生物制药公司，该公司通过其全资运营子公司NeuroRx, Inc.开发和分销用于治疗中枢神经系统疾病（包括自杀性抑郁症、慢性疼痛、创伤后应激障碍以及现在的精神分裂症）的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.074525},{"month":2,"riseRate":0.2,"avgChangeRate":-0.102766},{"month":3,"riseRate":0.4,"avgChangeRate":-0.034339},{"month":4,"riseRate":0.4,"avgChangeRate":-0.100305},{"month":5,"riseRate":0.8,"avgChangeRate":0.153649},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.15132},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.005215},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.100965},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.037466},{"month":10,"riseRate":0.5,"avgChangeRate":0.014683},{"month":11,"riseRate":0.4,"avgChangeRate":0.048439},{"month":12,"riseRate":0.6,"avgChangeRate":0.121824}],"exchange":"NASDAQ","name":"NRX Pharmaceuticals Inc.","nameEN":"NRX Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NRX Pharmaceuticals Inc.(NRXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NRX Pharmaceuticals Inc.,NRXP,NRX Pharmaceuticals Inc.股票,NRX Pharmaceuticals Inc.股票老虎,NRX Pharmaceuticals Inc.股票老虎国际,NRX Pharmaceuticals Inc.行情,NRX Pharmaceuticals Inc.股票行情,NRX Pharmaceuticals Inc.股价,NRX Pharmaceuticals Inc.股市,NRX Pharmaceuticals Inc.股票价格,NRX Pharmaceuticals Inc.股票交易,NRX Pharmaceuticals Inc.股票购买,NRX Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NRX Pharmaceuticals Inc.(NRXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}